| Literature DB >> 35005607 |
Md Samiul Islam1, Sultana Parvin2, Mohammad Mahbubur Rahman Khan1, G M Jahangir Hossain1, A K M Zahiruddin1, Md Jahangir Alam1, Monaim Hossen1, Md Wahidur Rahman1, Syed Shahidul Islam1, Md Abdul Gani Mollah1.
Abstract
Introduction: Asymptomatic COVID-19 patients are the most challenging and feared obstacles in resuming these surgical procedures. The purpose of this study was to evaluate the proportion of asymptomatic carriers detected by RT-PCR in pre-operative orthopaedic evaluation during the peak of the second wave.Entities:
Keywords: Asymptomatic; COVID-19; Orthopaedic surgery; RT-PCR; Second wave
Year: 2022 PMID: 35005607 PMCID: PMC8721921 DOI: 10.1016/j.clinpr.2021.100131
Source DB: PubMed Journal: Clin Infect Pract ISSN: 2590-1702
Clinicodemographic characteristics of the patients (n = 514).
| Characteristics | Group | Mean ± SD | Ratio | n(%) |
|---|---|---|---|---|
| Age (in years) | <20 | 12(2.3) | ||
| 21–40 | 61.17 ± 16.73 | 97(18.8) | ||
| 41–60 | 154(29.9) | |||
| >60 | 251(48.8) | |||
| Sex | Male | 363(63.4) | ||
| Female | 151(36.5) | |||
| Male Female ratio | 1:0.41 | |||
| Co-morbidities | HTN | 183(36.7) | ||
| DM | 164(31.9) | |||
| BA | 49(9.5) | |||
| IHD | 38(7.3) | |||
| CKD | 17(3.3) | |||
| Carcinoma | 13(2.5) | |||
| COPD | 10(1.9) | |||
| Liver Disease | 9(1.7) | |||
| IBD | 3(0.5) | |||
| Others | 5(0.9) | |||
| Admission to RT-PCR test interval | 07 Days | 96(18.6) | ||
| 14 Days | 161(31.3) | |||
| 30 Days | 149(28.9) | |||
| 45 Days | 108(21.0) | |||
| RT-PCR test result | Positive | 63(12.3) | ||
| Negative | 451(87.7) | |||
Values are presented as frequency, percentage (in the parenthesis), mean ± Standard Deviation (SD),
hypertension (HTN), diabetes mellitus (DM), bronchial asthma (BA), ischemic heart disease (IHD),
chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD),
Inflammatory Bowel Disease (IBD)
Types elective orthopaedic procedures performed (n = 514).
| Elective orthopaedic procedures | No. of | Sex | |
|---|---|---|---|
| performed | cases | Male | Female |
| Hip | |||
| Primary hip arthroplasty | 148 | 99 | 49 |
| Revision hip arthroplasty | 4 | 3 | 1 |
| Excision of trochanteric bursa | 2 | 1 | 1 |
| Knee | |||
| Primary knee arthroplasty | 4 | 1 | 3 |
| Revision knee arthroplasty | 1 | 0 | 1 |
| Unicompartmental knee arthroplasty | 1 | 1 | 0 |
| Knee arthroscopic procedures | 127 | 104 | 23 |
| Excision of cystic swelling around the knee | 3 | 2 | 1 |
| Foot & Ankle | |||
| Tendo-Achilles reconstruction | 7 | 3 | 4 |
| Tibiotalocalcaneal fusion | 3 | 2 | 1 |
| Metatarsophalangeal joint fusion with osteotomy | 2 | 1 | 1 |
| Zadek’s procedure (great toe) | 2 | 1 | 1 |
| Shoulder | |||
| Shoulder arthroscopic procedures | 66 | 54 | 12 |
| Latarjet procedure | 23 | 17 | 6 |
| Primary shoulder arthroplasty | 4 | 3 | 1 |
| Revision shoulder arthroplasty | 1 | 1 | 0 |
| Pectoralis major repair | 1 | 1 | 0 |
| Manipulation under anaesthesia (MUA) | 2 | 2 | 0 |
| Wrist and Hand | |||
| Carpel tunnel decompression | 24 | 8 | 16 |
| Release of trigger finger | 11 | 5 | 6 |
| De Quervain's release | 7 | 4 | 3 |
| Spine | |||
| Spinal decompression with/without discectomy | 19 | 13 | 6 |
| Epidural injection | 7 | 5 | 2 |
| Removal of fixation devices | |||
| Upper limb | 7 | 6 | 1 |
| Lower limb | 11 | 8 | 3 |
| All other procedures | 27 | 18 | 9 |
| Total | 514 | 363 | 151 |
Comparison of demography, symptoms and co-morbidity between asymptomatic RT-PCR positive and RT-PCR Negative cases (n = 514).
| Characteristics | Asymptomatic RT-PCR positive (n = 63) | Asymptomatic RT-PCRNegative (n = 451) | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Age (Mean ± SD) | 47.35 ± 14.37 | 60.53 ± 14.32 | a0.001 s | ||
| Sex | |||||
| Male | 37 | 58.7 | 326 | 72.1 | b0.026 s |
| Female | 26 | 41.3 | 125 | 27.9 | |
| Male:Female | 1:0.70 | 1:0.38 | |||
| Admission to RT-PCR test interval | |||||
| Days (Mean ± SD) | 46 ± 7.32 | 29 ± 11.62 | a0.001 s | ||
| Co-morbidity | |||||
| HTN | 19 | 30.1 | 184 | 40.7 | b0.335 ns |
| DM | 14 | 22.2 | 150 | 33.2 | b0.078 ns |
| BA | 11 | 17.4 | 38 | 8.4 | b0.022 s |
| IHD | 8 | 12.6 | 30 | 6.6 | b0.119 ns |
| CKD | 4 | 6.3 | 13 | 2.8 | b0.149 s |
| Carcinoma | 3 | 4.7 | 10 | 2.2 | b0.228 ns |
| COPD | 2 | 3.1 | 8 | 1.7 | b0.450 ns |
| Liver Disease | 3 | 4.0 | 6 | 1.3 | b0.051 ns |
| IBD | 1 | 1.5 | 2 | 0.4 | b0.264 ns |
| Others | 2 | 3.1 | 3 | 0.6 | b0.057 ns |
s = significant, ns = not significant, a p-value from Unpaired t-test,b p-value from Chi-square test.
hypertension (HTN), diabetes mellitus (DM), bronchial asthma (BA), ischemic heart disease (IHD), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD)
p-value from z test of proportion, ReverseTranscription–polymerase Chain Reaction (RT-PCR),
Factor predicting asymptomatic RT-PCR for COVID-19 positive case.
| Factors | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| Age | ||||||
| < 50 Years | 3.81 | 1.31–13.07 | 0.005 s | 1.207 | 0.923–2.988 | 0.001 s |
| Sex | ||||||
| Female | 1.13 | 0.64–1.99 | 0.065 ns | 8.081 | 1.326–49.572 | 0.025 s |
| Admission to RT-PCR test interval | ||||||
| >30 days | 0.54 | 0.83–1.09 | 0.045 s | 7.058 | 1.234–36.743 | 0.034 s |
s = significant, ns = not significant
Coronavirus Disease 2019 (COVID-19)
Reverse Transcription–polymerase Chain Reaction (RT-PCR)
Factor analysis was done by logistic regression
Risk measurement (hazard ratios) for being COVID-19 Positive among asymptomatic RT-PCR positive compared to asymptomatic RT-PCR negative patients at 7,14,30 and 45 Days after admission.
| Duration of riskmeasure | Hazard Ratio Value | 95% CI | |
|---|---|---|---|
| 07 Days | 3.4 | 0.11–76.0 | 0.385 |
| 14 Days | 4.3 | 1.3–19.8 | 0.025 |
| 30 Days | 4.1 | 1.1–15.9 | 0.056 |
| 45 Days | 9.2 | 0.9–91.2 | 0. 049 |
Reverse Transcription–polymerase Chain Reaction (RT-PCR)
Coronavirus Disease 2019 (COVID-19)